Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation

January 10, 2023

Biotechnology

INmune Bio, Inc. Announces Pre-Clinical Data That Support a Pioneering Approach to Treating Duchenne Muscular Dystrophy

January 25, 2023
First Wave BioPharma Announces Expansion of Adrulipase Intellectual Property Portfolio

January 25, 2023
First Wave BioPharma to Present at Sequire Biotechnology Conference

January 24, 2023
Qualigen Therapeutics Initiates Good Laboratory Practice (GLP) Toxicology Studies on QN-302

January 24, 2023